These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 23435355)
1. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway. Quan HY; Kim DY; Kim SJ; Jo HK; Kim GW; Chung SH Biochem Pharmacol; 2013 May; 85(9):1330-40. PubMed ID: 23435355 [TBL] [Abstract][Full Text] [Related]
2. Eugenol ameliorates hepatic steatosis and fibrosis by down-regulating SREBP1 gene expression via AMPK-mTOR-p70S6K signaling pathway. Jo HK; Kim GW; Jeong KJ; Kim DY; Chung SH Biol Pharm Bull; 2014; 37(8):1341-51. PubMed ID: 25087956 [TBL] [Abstract][Full Text] [Related]
3. Beneficial effect of betulinic acid on hyperglycemia via suppression of hepatic glucose production. Kim SJ; Quan HY; Jeong KJ; Kim DY; Kim Gw; Jo HK; Chung SH J Agric Food Chem; 2014 Jan; 62(2):434-42. PubMed ID: 24354358 [TBL] [Abstract][Full Text] [Related]
4. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes. Seo MS; Kim JH; Kim HJ; Chang KC; Park SW Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164 [TBL] [Abstract][Full Text] [Related]
5. Dapagliflozin attenuates steatosis in livers of high-fat diet-induced mice and oleic acid-treated L02 cells via regulating AMPK/mTOR pathway. Luo J; Sun P; Wang Y; Chen Y; Niu Y; Ding Y; Xu N; Zhang Y; Xie W Eur J Pharmacol; 2021 Sep; 907():174304. PubMed ID: 34224699 [TBL] [Abstract][Full Text] [Related]
6. Emodin alleviates hepatic steatosis by inhibiting sterol regulatory element binding protein 1 activity by way of the calcium/calmodulin-dependent kinase kinase-AMP-activated protein kinase-mechanistic target of rapamycin-p70 ribosomal S6 kinase signaling pathway. Wang S; Li X; Guo H; Yuan Z; Wang T; Zhang L; Jiang Z Hepatol Res; 2017 Jun; 47(7):683-701. PubMed ID: 27492505 [TBL] [Abstract][Full Text] [Related]
7. Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor. Liu M; Zhang G; Wu S; Song M; Wang J; Cai W; Mi S; Liu C J Ethnopharmacol; 2020 Jun; 255():112776. PubMed ID: 32205261 [TBL] [Abstract][Full Text] [Related]
8. S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway. Hwang YP; Kim HG; Choi JH; Do MT; Chung YC; Jeong TC; Jeong HG J Nutr Biochem; 2013 Aug; 24(8):1469-78. PubMed ID: 23465592 [TBL] [Abstract][Full Text] [Related]
9. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399 [TBL] [Abstract][Full Text] [Related]
10. Berbamine induced AMPK activation regulates mTOR/SREBP-1c axis and Nrf2/ARE pathway to allay lipid accumulation and oxidative stress in steatotic HepG2 cells. Sharma A; Anand SK; Singh N; Dwivedi UN; Kakkar P Eur J Pharmacol; 2020 Sep; 882():173244. PubMed ID: 32526241 [TBL] [Abstract][Full Text] [Related]
11. Licochalcone A regulates hepatic lipid metabolism through activation of AMP-activated protein kinase. Quan HY; Kim SJ; Kim DY; Jo HK; Kim GW; Chung SH Fitoterapia; 2013 Apr; 86():208-16. PubMed ID: 23500383 [TBL] [Abstract][Full Text] [Related]
12. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway. Zhang J; Du H; Shen M; Zhao Z; Ye X J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949 [TBL] [Abstract][Full Text] [Related]
13. Betulinic acid inhibits high-fat diet-induced obesity and improves energy balance by activating AMPK. Kim KD; Jung HY; Ryu HG; Kim B; Jeon J; Yoo HY; Park CH; Choi BH; Hyun CK; Kim KT; Fang S; Yang SH; Kim JB Nutr Metab Cardiovasc Dis; 2019 Apr; 29(4):409-420. PubMed ID: 30799179 [TBL] [Abstract][Full Text] [Related]
14. LRG ameliorates steatohepatitis by activating the AMPK/mTOR/SREBP1 signaling pathway in C57BL/6J mice fed a high‑fat diet. Hao T; Chen H; Wu S; Tian H Mol Med Rep; 2019 Jul; 20(1):701-708. PubMed ID: 31180545 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway. Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683 [TBL] [Abstract][Full Text] [Related]
17. MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway. Chu H; Du C; Yang Y; Feng X; Zhu L; Chen J; Yang F Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548730 [TBL] [Abstract][Full Text] [Related]
18. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861 [TBL] [Abstract][Full Text] [Related]
19. A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression. Hwang HJ; Jung TW; Kim BH; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ Biochem Pharmacol; 2015 Nov; 98(1):157-66. PubMed ID: 26297911 [TBL] [Abstract][Full Text] [Related]
20. Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathway. Chen Q; Liu M; Yu H; Li J; Wang S; Zhang Y; Qiu F; Wang T J Nat Med; 2018 Jun; 72(3):655-666. PubMed ID: 29542003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]